Source: Virtual Congress 2021 – COVID - 19 treatments



Rating:

Share or cite this content

Citations should be made in the following way:
B. Gonzalez Quero (Barakaldo, Spain), L. Serrano Fernández (Barakaldo, Spain), A. Rezola Carasusan (Barakaldo, Spain), M. García Moyano (Barakaldo, Spain), S. Castro Quintas (Barakaldo, Spain), A. Urrutia Gajate (Barakaldo, Spain), L. Ruiz Iturriaga (Barakaldo, Spain), R. Zalacain Jorge (Barakaldo, Spain). UTILITY OF BRONCHOALVEOLAR LAVAGE(BAL) TO DETECT INFECTIOUS COMPLICATIONS IN PATIENTS WITH SEVERE SARS-COV-2 PNEUMONIA. 3678

Member's Comments

No comment yet.

Related content which might interest you: FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY. Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 PLEURAL EFFUSION IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 SURFACTANT THERAPY IN PATIENTS WITH SEVERE UNCONTROLLED BRONCHIAL ASTHMA Source: International Congress 2018 – New modalities in asthma treatment Year: 2018 DIAGNOSTICS, THERAPY, COURSE AND RESULTS IN PATIENTS WITH CHRONIC EXTRINSIC ALLERGIC ALVEOLITIS. Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 LONG –TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL AND LEGIONELLA PNEUMONIA Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS AND NORMAL OR BORDERLINE PULMONARY PRESSURES Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 UTILITY OF THE HIGH FLOW WITH NASAL CANNULA IN THE DECANULATION OF TRAQUEOTOMIZED PATIENTS DURING AN EPISODE OF ACUTE RESPIRATORY INSUFFICIENCY. Source: International Congress 2018 – New tools for managing respiratory failure Year: 2018 EXTRARESPIRATORY SYMPTOM BURDEN IN PATIENTS HOSPITALIZED FOR A COPD EXACERBATION: IT’S NOT ONLY ABOUT RESPIRATORY SYMPTOMS Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 SYSTEMIC INFLAMMATION IN PATIENTS WITH STABLE NON-CYSTIC FIBROSIS BRONCHIECTASIS Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 AWAKE PRONE POSITION IN CRITICAL AND SEVERE COVID-19 PATIENTS UNDERGOING NONINVASIVE RESPIRATORY SUPPORT: A RETROSPECTIVE MULTICENTER COHORT STUDY. Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 LYMPHOPENIA AS PREDICTOR OF LONG TERM MORTALITY IN PATIENTS WITH HOSPITAL ACQUIRED PNEUMONIA Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018